Shandong Weigao Group Medical Polymer Co (1066) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1066 Analyst Ratings

Currently, no data available

Based on NaN analysts giving stock ratings to

Shandong

Weigao Group Medical Polymer Co

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1066 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1066 In The Last 3 Months.

Highest Price Target―

Average Price Target―

Lowest Price Target―

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1066 Financial Forecast

1066 Earnings Forecast

Next quarter’s earnings estimate for 1066 is HK$0.26 with a range of HK$0.26 to HK$0.26. The previous quarter’s EPS was HK$0.24. 1066 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1066 has Preformed in-line its overall industry.

1066 Sales Forecast

Next quarter’s sales forecast for 1066 is HK$7.97B with a range of HK$7.97B to HK$7.97B. The previous quarter’s sales results were HK$7.14B. 1066 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1066 has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$6.2

Hold

11.71%

Upside

Reiterated

10/19/25

Morgan Stanley Sticks to Its Hold Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)

Unknown Analyst

UBS

Not Ranked

UBS

HK$8.2

Buy

47.75%

Upside

Reiterated

10/17/25

Jack Scalprey

TR | OpenAI - 4o

HK$6.5

Hold

17.12%

Upside

Reiterated

10/14/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

HK$8.76

Buy

57.84%

Upside

Reiterated

09/18/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$7.5

Buy

35.14%

Upside

Reiterated

08/29/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$6.4

Buy

15.32%

Upside

Reiterated

08/29/25

Jialin Zhang

Nomura

HK$6.29→HK$7.08

Buy

27.57%

Upside

Reiterated

07/15/25

Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy from Nomura

David Shang

Jefferies

HK$5.2

Buy

-6.31%

Downside

Reiterated

01/22/25

Jefferies Remains a Buy on Shandong Weigao Group Medical Polymer Co (SHWGF)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$6.2

Hold

11.71%

Upside

Reiterated

10/19/25

Morgan Stanley Sticks to Its Hold Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)

Unknown Analyst

UBS

Not Ranked

UBS

HK$8.2

Buy

47.75%

Upside

Reiterated

10/17/25

Jack Scalprey

TR | OpenAI - 4o

HK$6.5

Hold

17.12%

Upside

Reiterated

10/14/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

HK$8.76

Buy

57.84%

Upside

Reiterated

09/18/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$7.5

Buy

35.14%

Upside

Reiterated

08/29/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$6.4

Buy

15.32%

Upside

Reiterated

08/29/25

Jialin Zhang

Nomura

HK$6.29→HK$7.08

Buy

27.57%

Upside

Reiterated

07/15/25

Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy from Nomura

David Shang

Jefferies

HK$5.2

Buy

-6.31%

Downside

Reiterated

01/22/25

Jefferies Remains a Buy on Shandong Weigao Group Medical Polymer Co (SHWGF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shandong Weigao Group Medical Polymer Co

1 Month

xxx

Success Rate

4/11 ratings generated profit

Average Return

-1.18%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 36.36% of your transactions generating a profit, with an average return of -1.18% per trade.

3 Months

xxx

Success Rate

6/11 ratings generated profit

Average Return

+3.60%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +3.60% per trade.

1 Year

Jialin ZhangNomura

Success Rate

4/11 ratings generated profit

Average Return

-7.13%

reiterated a buy rating 4 months ago

Copying Jialin Zhang's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -7.13% per trade.

2 Years

xxx

Success Rate

2/11 ratings generated profit

Average Return

-29.09%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 18.18% of your transactions generating a profit, with an average return of -29.09% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1066 Analyst Recommendation Trends

Rating

Jan 25

Jun 25

Jul 25

Aug 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1066 has received 1 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 1066 average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

1066 Stock Forecast FAQ

What is HK:1066’s average 12-month price target, according to analysts?

Currently, no data Available

What is HK:1066’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HK:1066, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Shandong Weigao Group Medical Polymer Co Class H a Buy, Sell or Hold?

Currently, no data Available

What is Shandong Weigao Group Medical Polymer Co Class H’s share price target?

Currently, no data Available

What do analysts say about Shandong Weigao Group Medical Polymer Co Class H?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of Shandong Weigao Group Medical Polymer Co Class H?

To buy shares of HK:1066, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Shandong Weigao Group Medical Polymer Co (1066) Stock Forecast & Price Target

1066 Analyst Ratings

1066 Stock 12 Month Forecast

1066 Financial Forecast

1066 Earnings Forecast

1066 Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Shandong Weigao Group Medical Polymer Co

1066 Analyst Recommendation Trends

1066 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts